2076975 2077203
최종편집 2024-06-20 20:13 (목)
10 pharmaceutical stocks enter the top 200 securities market stock price increase in 3Q
상태바
10 pharmaceutical stocks enter the top 200 securities market stock price increase in 3Q
  • Hyeokgi Lee, Newsmp
  • 승인 2022.10.12 19:14
  • 댓글 0
이 기사를 공유합니다

Ilsung Pharmaceutical 40.3%↑ 16th… Ildong Holdings 44th with 19.5%
Samjin PharmaceuticalㆍKorea United Pharm. rose more than 5%

[Newsmp] Many of the pharmaceutical stocks plummeted in the third quarter, but there were also a number of stocks that entered the top stock price increase ranking.

Stock prices of 50 out of 59 pharmaceutical-related stocks (including preferred stocks and holding stocks) fell in the securities market in the third quarter (based on revised stock price), according to the Korea Exchange.

Among them, 38 stocks recorded double-digit drops, and 14 stocks plunged more than 20%.

On the other hand, only nine pharmaceutical stocks saw their stock prices rise during the same period, and only two of them recorded double-digit gains.

Nevertheless, 10 pharmaceutical stocks were listed in the top 200 stock price increase in the third quarter of the 937 listed stocks in the securities market.

 

 

In particular, Ilsung Pharmaceutical’s stock price jumped 40.3% and ranked 16th during this period, and Ildong Holdings also recorded a double-digit increase of 19.5% and entered the top 50 at 44th.

Along with them, Samjin Pharmaceutical, which achieved a 6.5% increase, and Korea United Pharm., which rose 6.1%, ranked 94th and 96th.

Hyundai Pharmaceutical and Samil Pharmaceutical recorded a 4% range price increase, ranking 118th and 119th, followed by Whanin Pharmaceutical at 3.7% at 124th, Boryung Pharmaceutical at 2.5% at 136th, and Samsung Biologics at 2.2% at 140th.

The stock price of Dong-A Socio Holdings slipped 1.5% during the same period, but it was ranked 198th in the top 200.

Celltrion, Daewon Pharmaceutical, Yuhan Corporation, Yuhan Corp. Pfd. Series 1, and Kwang Dong Pharmaceutical, which blocked the fall within 5%, were in the top 300.

Moreover, Yuyu Pharma, Gene One Life Science, JW Pharmaceutical Corp. Pfd. Series 1, Yuyu Pharma Inc. Pfd. Series 1, and Shin Poong Pharmaceutical entered the top 400 with a single-digit drop, ranking above the middle of the securities market despite the stock price decrease.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.